Advertisement
Home »

Primary Treatment Modification and Treatment Tolerability Among Older Chemotherapy Recipients With Advanced Cancer.

Feb 19, 2024

ABOUT THE CONTRIBUTORS

  • Mostafa R Mohamed

    Division of Hematology/Oncology, James P. Wilmot Cancer Institute, Department of Medicine, University of Rochester, Rochester, New York.

    David Q Rich

    Department of Public Health, University of Rochester School of Medicine and Dentistry, Rochester, New York.

    Christopher Seplaki

    Department of Public Health, University of Rochester School of Medicine and Dentistry, Rochester, New York.

    Jennifer L Lund

    Department of Epidemiology, University of North Carolina, Chapel Hill.

    Marie Flannery

    University of Rochester School of Nursing, Rochester, New York.

    Eva Culakova

    Department of Surgery, University of Rochester School of Medicine and Dentistry, Rochester, New York.

    Allison Magnuson

    Division of Hematology/Oncology, James P. Wilmot Cancer Institute, Department of Medicine, University of Rochester, Rochester, New York.

    Megan Wells

    Division of Hematology/Oncology, James P. Wilmot Cancer Institute, Department of Medicine, University of Rochester, Rochester, New York.

    Rachael Tylock

    Division of Hematology/Oncology, James P. Wilmot Cancer Institute, Department of Medicine, University of Rochester, Rochester, New York.

    Supriya G Mohile

    Division of Hematology/Oncology, James P. Wilmot Cancer Institute, Department of Medicine, University of Rochester, Rochester, New York.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement